Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
Go back to Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases| RITE AID CORPORATION (NYSE: RAD) | Delayed: 0.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $8.30 | |||
| Open | $11.16 | 52 Week Low | $6.33 | |||
| Day High | $0.65 | P/E | 1.91 | |||
| Day Low | $0.65 | EPS | $0.34 | |||
| Volume | 63,391 | |||||
| (NASDAQ: RADX) | Delayed: 3.65 -0.64 (14.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.29 | 52 Week High | $ | |||
| Open | $2.87 | 52 Week Low | $ | |||
| Day High | $3.94 | P/E | N/A | |||
| Day Low | $2.73 | EPS | $ | |||
| Volume | 1,333,944 | |||||
